20.500.12556/DiRROS-8154
Letno srečanje ASCO
ASCO Annual Meeting
In the end of May this year, Chicago hosted the traditional annual meeting of oncologists from around the world, which was organised by the American Society of Clinical Oncology (ASCO). Once again, the meeting was attended by more than 30,000 oncologists and other scientists from all over the world. The main topic of this year’s ASCO meeting was definitely cancer immunotherapy. For many years, we have hoped to be able to destroy or at least control cancer cells by stimulating the organism’s own defence. There have been some ups but mostly many downs of immunotherapy. Interferons, interleukins and vaccines have shown a very small level of efficacy, and, even so, only in some types of cancer, alongside a disproportionally high toxicity. A breakthrough was achieved a few years ago, when new immuno-medicines, inhibitors of control switches in T lymphocytes (so-called checkpoint inhibitors), were introduced into clinical trials. In many types of cancer, these medicines led to remissions, which were, most importantly, long-term in patients with remission.
klinična onkologija
imunoterapija
imunska zdravila
novosti
true
false
false
Slovenski jezik
Angleški jezik
by Authors
Neznano
2018-01-03 12:27:28
2018-03-19 11:32:04
2022-08-16 09:56:52
0000-00-00 00:00:00
2015
0
0
str. 30-32
št. 1
Letn. 19
jun. 2015
0000-00-00
Zaloznikova
Objavljeno
NiDoloceno
0000-00-00
0000-00-00
0000-00-00
616-006
1408-1741
2139771
65324032
RAZ_Cufer_Tanja_i2015.pdf
RAZ_Cufer_Tanja_i2015.pdf
1
DB394AED358E995AD5C6942B5420B414
913738df4526980ada02afcf96be425644ede94fd07144dc1c96bd13c3d2af76
4860ef7f-17b5-11ed-b6b8-001a4af901a5
20.500.12556/dirros/350c04b1-ea3d-4086-8a08-de974893dc0a
https://dirros.openscience.si/Dokument.php?lang=slv&id=10110
Onkološki inštitut Ljubljana
Onkologija : strokovni časopis za zdravnike
0
0
0